ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1491

M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients

Ida G. Louw1, Christian G. Ammitzböll2, Brian Bridal Løgstrup3, Jesper Blegvad-Nissen4, Grazina Urbonaviciene4, Trine Bay Laurberg4, Mette Herly5, Agnete H. Nielsen4, Steffen Thiel6 and Torkell Ellingsen5, 1University of Southern Denmark, Odense, DK, Odense, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, DK, Aarhus, Denmark, 3Department of Cardiology, Skejby, Aarhus University Hospital, Aarhus, DK, Aarhus, Denmark, 4Diagnostic Centre, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, DK, Silkeborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, DK, Odense, Denmark, 6Institute of Biomedicine, Aarhus University, Aarhus, DK, Aarhus, Denmark

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cardiovascular disease and rheumatoid arthritis (RA), Pulmonary Involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  The aim was to investigate M-ficolin and Map44, proteins from the lectin pathway, as prognostic markers of subclinical cardiovascular disease in untreated early rheumatoid arthritis (RA) patients. We evaluated the associations between M-ficolin, MAp44 and disease activity (DAS28, CRP and HAQ-score), the degree of coronary artery calcification and myocardial deformation of left ventricle in an inception cohort.

Methods:  79 DMARD-naïve RA patients with a disease duration < 6 months were included from an inception cohort. Clinical variables, plasma- and serum-M-ficolin and MAp44 levels, myocardial deformation analysis and coronary calcification were measured at baseline and after two years. M-ficolin and Map44 were measured with an in-house time-resolved flourometric immunoassay. Coronary calcification was evaluated by Agatston calcium-score using cardiac computer tomography. Left ventricle deformation imaging was determined by speckle tracking echocardiography. Level of statistical dependence and significance were determined with Spearman rank correlation test.

Results:  Baseline serum M-ficolin was associated to CRP (r=0.26, p=0.02) and DAS28 (r=0.24, p=0.04). Further, baseline Map44 was associated to CRP in serum (r=0.25, p=0.03) and plasma (r=0.29, p=0.01). At the two-year follow-up patient’s global assessment, assessment of pain, fatigue and HAQ score were associated to serum MAp44 (range p=0.002; 0.04), (range r=-0.36; -0.25). We found associations between baseline fasting insulin and M-ficolin and MAp44 (range p=0.001; 0.02). No associations were found between Agatston calcium score and MAp44 or M-ficolin. Only baseline plasma MAp44 showed association to global longitudinal strain (GLS) (r=0.27, p=0.03).

Conclusion:   M-ficolin and MAp44 were associated with disease activity markers and plasma insulin at baseline and at two-year follow-up. GLS and MAp44 were positively associated at baseline.


Disclosure: I. G. Louw, None; C. G. Ammitzböll, None; B. B. Løgstrup, None; J. Blegvad-Nissen, None; G. Urbonaviciene, None; T. Bay Laurberg, None; M. Herly, None; A. H. Nielsen, None; S. Thiel, None; T. Ellingsen, None.

To cite this abstract in AMA style:

Louw IG, Ammitzböll CG, Løgstrup BB, Blegvad-Nissen J, Urbonaviciene G, Bay Laurberg T, Herly M, Nielsen AH, Thiel S, Ellingsen T. M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/m-ficolin-and-map44-as-potential-markers-of-subclinical-cardiovascular-comorbidity-cardiac-evaluation-by-coronary-computer-tomography-and-myocardial-deformation-of-left-ventricle-in-early-rheumatoid/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/m-ficolin-and-map44-as-potential-markers-of-subclinical-cardiovascular-comorbidity-cardiac-evaluation-by-coronary-computer-tomography-and-myocardial-deformation-of-left-ventricle-in-early-rheumatoid/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology